ERBB2 and breast cancer: Studies have reported that HER2-positive (HR-negative) BC exhibits the highest rates of breast pCR (bpCR) and nodal pCR (npCR), and HER2-negative (HR-positive) BC exhibits the lowest rates of bpCR (26).